Axsome Therapeutics is trading at $163.88, up 5.18%; no company-specific catalyst for the October 20 move surfaced in the search.
- The latest company update found was its October 7 notice that third-quarter results will be reported November 2.
- Biotech was up 2.10%; cited M&A activity and positive clinical-trial data may support the move, but do not establish a direct cause.
- An early-session snapshot had conflicting prices, so the supplied live price context is used.